发表研究结果有使用 ab214565?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab214565 被引用在 5 文献中.

  • Gong B  et al. Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med 216:982-1000 (2019). PubMed: 30872362
  • Zhou J  et al. Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma. Exp Ther Med 15:4979-4986 (2018). PubMed: 29805521
  • Costantini A  et al. Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab. Oncoimmunology 7:e1452581 (2018). PubMed: 30221046
  • Xie Q  et al. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population. Gene 674:188-194 (2018). PubMed: 29940275
  • Kawamoto E  et al. Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis. Shock N/A:N/A (2018). PubMed: 30036273

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

注册